DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
83. アジソン病
Addison disease
Clinical trials
/
Disease details
臨床試験数
:
20
/
薬物数
:
39
- (
DrugBank
:
13
) /
標的遺伝子数
:
6
-
標的パスウェイ数
:
18
Search
1 trial found
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
EUCTR2012-001682-33-GB
(
EUCTR
)
06/09/2012
15/06/2012
Rescue of Addison’s disease 2
Combined Immunotherapy and Trophic Adrenocortical Stimulation in New Onset Autoimmune Addison’s Disease - Rescue of Addison’s disease 2 (RADS2)
Combined Immunotherapy and Trophic Adrenocortical Stimulation in New Onset Autoimmune Addison’s Dise ...
Autoimmune Addison's disease: autoimmune primary adrenal insufficiency
MedDRA version: 16.1;Level: PT;Classification code 10052381;Term: Primary adrenal insufficiency;System Organ Class: 10014698 - Endocrine disorders
MedDRA version: 16.1;Level: LLT;Classification code 10001335;Term: Adrenal cortex insufficiency;Classification code 10001342;Term: Adrenal cortical hypofunction;System Organ Class: 10014698 - Endocrine disorders ;Therapeutic area: Diseases [C] - Hormonal diseases [C19]
Autoimmune Addison's disease: autoimmune primary adrenal insufficiency
MedDRA version: 16.1;Level: P ...
Trade Name:
Mabthera
infusion
Product Name:
Mabthera
Infusion
Product Code:
Rituximab
Trade Name:
Solu-Medrone
Product Name:
Solu-Medrone
Product Code:
Methylprednisolone
Trade Name:
Synacthen Depot
Product Name:
Synacthen Depot
Product Code:
Tetracosactide
acetate
Trade Name:
Mabthera
infusion
Product Name:
Mabthera
Infusion
Product Code:
Rituximab
Trade Name:
Solu-Me
...
Newcastle upon Tyne Hospitals NHS Foundation Trust
NULL
Not Recruiting
Female: yes
Male: yes
30
Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): no
Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...
United Kingdom